| |
Non-vascularised bone graft
|
Vascularised bone graft
|
|---|
|
Author
|
Year of publication
|
No. of patients who had implants placed into non-vascularised autogenous bone grafts (and failures)
|
Overall patient implant survival in non-vascularised autogenous bone grafts
|
No. of implants placed into non-vascularised autogenous bone grafts (and failures)
|
Overall implant survival in non-vascularised autogenous bone grafts
|
No. of patients who had implants placed into vascularized autogenous bone grafts (and failures)
|
Overall patient implant survival in vascularised autogenous bone grafts
|
No. of implants placed into vascularised autogenous bone grafts (and failures)
|
Overall implant survival in vascularised autogenous bone grafts
|
|---|
|
Studies with an average follow-up of 3 years or greater
|
|
Watzinger et al. [29]
|
1996
|
Not reported
|
N/A
|
33 (13)
|
60.6%*
|
Not reported
|
N/A
|
19 (1)
|
94.7%*
|
|
Teoh et al. [26]
|
2005
|
N/A
|
N/A
|
N/A
|
N/A
|
22 (2)
|
90.9%*
|
71 (3)
|
95.8%*
|
|
Wu et al. [30]
|
2008
|
N/A
|
N/A
|
N/A
|
N/A
|
29 (not reported)
|
N/A
|
100 (9)
|
91%
|
|
Fenlon et al. [19]
|
2012
|
N/A
|
N/A
|
N/A
|
N/A
|
41 (10)
|
75.6%*
|
145 (18)
|
87.5%*
|
|
Ch’ng et al. [20]
|
2014
|
N/A
|
N/A
|
N/A
|
N/A
|
54 (10)
|
81.5%*
|
243 (20)
|
91.8%
|
|
Shaw et al. [31]
|
2005
|
2 (1)
|
50%*
|
8 (2)
|
75%*
|
31 (11)
|
64.5%*
|
115 (30)
|
73.9%*
|
|
Wang et al. [21]
|
2015
|
N/A
|
N/A
|
N/A
|
N/A
|
19 (0)
|
100%
|
51 (0)
|
100%*
|
|
Yerit et al. [16]
|
2006
|
Not reported
|
N/A
|
Not reported
|
N/A
|
Not reported
|
N/A
|
Not reported
|
N/A
|
|
Linsen et al. [17]
|
2009
|
Not reported
|
N/A
|
79 (8)
|
89.9%*
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Studies with an average follow-up of less than 3 years or no average follow-up reported
|
|
Fierz et al. [25]
|
2013
|
N/A
|
N/A
|
N/A
|
N/A
|
Not reported
|
N/A
|
Not reported
|
N/A
|
|
Barrowman et al. [7]
|
2011
|
Not reported
|
N/A
|
6 (0)
|
100%*
|
Not reported
|
N/A
|
32 (5)
|
84.4%*
|
|
Zou et al. [22]
|
2013
|
N/A
|
N/A
|
N/A
|
N/A
|
32 (not reported)
|
N/A
|
110 (5)
|
96.4%
|
|
Schultes et al. [15]
|
2002
|
N/A
|
N/A
|
N/A
|
N/A
|
38 (2)
|
94.7%*
|
96 (2)
|
97.9%*
|
|
Buddula et al. [24]
|
2010
|
Not reported
|
N/A
|
Not reported
|
N/A
|
Not reported
|
N/A
|
Not reported
|
N/A
|
|
Klein et al. [32]
|
2009
|
Not reported
|
N/A
|
128 (22)
|
82.8%*
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Burgess et al. [27]
|
2017
|
N/A
|
N/A
|
N/A
|
N/A
|
59 (not reported)
|
N/A
|
199 (11)
|
93.6%
|
|
Chiapasco et al. [18]
|
2006
|
N/A
|
N/A
|
N/A
|
N/A
|
14 (1)
|
92.9%*
|
62 (1)
|
98.3%*
|
|
Chiapasco et al. [23]
|
2008
|
16 (1)
|
93.8%*
|
60 (2)
|
96.7%*
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Chiapasco et al. [33]
|
2000
|
10 (1)
|
90%*
|
41 (2)
|
95.1%*
|
8 (1)
|
87.5%*
|
31 (1)
|
96.8%*
|
|
Hessling et al. [28]
|
2015
|
Not Reported
|
N/A
|
62 (4)
|
93.5%*
|
Not reported
|
N/A
|
31 (4)
|
87.1%*
|
- Implant survival in autogenous bone grafts was extracted on a patient and implant level (where applicable) for all 20 studies included within this review that specifically reported on implant survival in either vascularised or non-vascularised autogenous bone grafts
- Those marked with an asterisk have had the survival percentages calculated by the authors due to their being adequate information/data within the studies to calculate this
